Information  X 
Enter a valid email address


  Print          Annual reports

Tuesday 13 April, 2021


Exercise of Share Options & Total Voting Rights

RNS Number : 2198V
13 April 2021

Idox plc

( ' Idox '   or the  ' Group '   or the  ' Company ' )

Exercise of Share Options &

Total Voting Rights


Idox plc (AIM: IDOX) a leading supplier of specialist information management solutions and services, announces that it has issued 982,935 new ordinary shares of 1 pence each in the Company pursuant to an exercise of options by several employees under its Idox plc Long Term Incentive Plans and Idox Plc Share Option Plan.

Applications have been made for the 982,935 new ordinary shares   to be admitted to trading on AIM ("Admission"). It is expected that Admission will occur at 8.00 a.m. on or around 14 April 2021.

The total number of Ordinary Shares in issue following Admission will be 446,162,433 . The Company holds 1,426,219 Ordinary Shares in treasury. Therefore the total number of Ordinary Shares with voting rights in the Company will be 444,736,214 .

The above figure of 444,736,214 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.



Idox plc

+44 (0) 870 333 7101

Chris Stone, Non-Executive Chairman

David Meaden, Chief Executive

Rob Grubb, Chief Financial Officer

Peel Hunt LLP (NOMAD and Broker)

+44 (0) 20 7418 8900

Edward Knight

Paul Gillam

Nick Prowting

MHP Communications

+ 44 (0) 203 128 8100

Reg Hoare 

 [email protected]

James Bavister

Amy O'Sullivan



About Idox plc

For more information see   @Idoxgroup  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t